)
Conduent (CNDT) investor relations material
Conduent Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
ASCEND 2026–2028 focuses on core solutions, portfolio optimization, stronger execution, organizational simplification and cost reduction; $106M of the $120M savings target has been identified.
Q3 continuing-operations revenue was $534M, down 11.7% YoY; Adjusted EBITDA rose 16.1% to $36M and margin reached 6.7%.
Public Transit was sold to Modaxo; the Tolling sale is expected to complete the Transportation exit, while focus shifts to Commercial and Government growth.
Qualified pipeline was $2.9B; YTD new-business wins reached $249M ACV and $473M TCV.
Financial highlights
Q3 continuing-operations revenue was $534M versus $605M; continuing-operations net loss was $40M versus $42M, while consolidated net loss was $49M versus $46M.
Adjusted EBITDA was $36M versus $31M; margin was 6.7% versus 5.1%, including $4M of stranded transportation costs.
Adjusted diluted EPS was $(0.11); GAAP diluted EPS from continuing operations was $(0.27), unchanged YoY.
Q3 operating cash flow was $(107)M and adjusted free cash flow was $(117)M; factoring delays and working-capital timing weighed on cash flow.
YTD Adjusted EBITDA was $102M versus $79M, with margin of 6.2% versus 4.3%; adjusted free cash flow improved to $(140)M from $(158)M.
Outlook and guidance
FY 2026 outlook reaffirmed: revenue of $2.15B–$2.25B and Adjusted EBITDA of $140M–$170M, with a 6.5%–7.6% margin range.
FY 2027 outlook: revenue of $2.15B–$2.25B, Adjusted EBITDA of $170M–$200M, 7.9%–8.9% margin and positive adjusted free cash flow.
FY 2028 outlook: revenue of $2.25B–$2.35B, Adjusted EBITDA of $210M–$250M, 9.3%–10.6% margin and adjusted free cash flow above 20% of Adjusted EBITDA.
Longer-term adjusted EBITDA margin model targets steady progress to 15%; net leverage is expected to decline to 1.5x in 2027 and 1.0x thereafter.
The 2026 Restructuring Program is expected to cost $50M–$70M and be completed by the end of H1 2027.
- ASCEND targets 2028 growth and positive free cash flow through cost cuts, focus and AI.CNDT
Investor Day 2026 - Q2 2026 revenue dropped 11.9% as divestitures and restructuring drive transformation.CNDT
Q2 2026 - Margins improved to 6.8% in Q1 2026 as government and transportation segments grew.CNDT
Q1 2026 - Proxy outlines director elections, auditor ratification, compensation, and strong ESG focus.CNDT
Proxy filing - Shareholders will vote on directors, auditor ratification, and executive pay, with strong governance and ESG focus.CNDT
Proxy filing - Key votes include director elections, auditor ratification, and executive pay approval.CNDT
Proxy filing - Adjusted EBITDA margin improved to 5.4% as cost actions offset a 4.2% revenue decline.CNDT
Q4 2025 - Q3 2024 delivered $807M revenue, $123M net income, and completed major divestitures.CNDT
Q3 2024 - 2024 saw revenue and EBITDA decline but margin resilience, debt reduction, and a positive 2025 outlook.CNDT
Q4 2024
)
)
)
)
)
)
)
)